Animal studies have shown that IL-18 can induce lung inflammation (122); in humans, elevated IL-18 levels have been observed in patients with idiopathic pulmonary fibrosis (123), ILD-related inflammatory myopathies (124), and RA-ILD (39). Here, IL18 is linked to interstitial lung disease.